Viewing Study NCT05235906


Ignite Creation Date: 2025-12-26 @ 5:23 PM
Ignite Modification Date: 2025-12-29 @ 9:22 AM
Study NCT ID: NCT05235906
Status: UNKNOWN
Last Update Posted: 2023-08-09
First Post: 2022-02-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Study of Surufatinib Combined With Sintilimab in the Treatment of Advanced Gastric Cancer
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module